MPM Asset Management

Latest statistics and disclosures from Mpm Asset Management's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are TRDA, DYN, ITOS, RPTX, HOWL, and represent 96.70% of Mpm Asset Management's stock portfolio.
  • Reduced shares in these 2 stocks: Harpoon Therapeutics (-$11M), Oncorus.
  • Sold out of its position in Oncorus.
  • Mpm Asset Management was a net seller of stock by $-12M.
  • Mpm Asset Management has $187M in assets under management (AUM), dropping by -8.44%.
  • Central Index Key (CIK): 0001263048

Tip: Access up to 7 years of quarterly data

Positions held by MPM Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Mpm Asset Management

Mpm Asset Management holds 7 positions in its portfolio as reported in the September 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Entrada Therapeutics Common (TRDA) 37.5 $70M 4.4M 15.80
 View chart
Dyne Therapeutics Common (DYN) 23.8 $44M 5.0M 8.96
 View chart
iTeos Therapeutics Common (ITOS) 16.1 $30M 2.7M 10.95
 View chart
Repare Therapeutics Common (RPTX) 14.5 $27M 2.2M 12.08
 View chart
Werewolf Therapeutics Common (HOWL) 4.9 $9.2M 4.3M 2.14
 View chart
Adaptimmune Therapeutics Sponsored ADR (ADAP) 2.6 $4.9M 6.3M 0.78
 View chart
Harpoon Therapeutics Common 0.7 $1.3M -90% 313k 4.03
 View chart

Past Filings by Mpm Asset Management

SEC 13F filings are viewable for Mpm Asset Management going back to 2011

View all past filings